Skip to main content Skip to main navigation menu Skip to site footer
Drugs and Therapy Studies

eISSN 2038-9507

  • Archives
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine

    Lisa L. Ross, Marjorie D. Robinson, Giampiero Carosi, Adriano Lazzarin, Hans-Juergen Stellbrink, Graeme Moyle, Naomi Givens, William G. Nichols
    e1
    30-12-2011
    https://doi.org/10.4081/dts.2012.e1
    2278
    PDF: 772
  • Bevacizumab and etoposide combination chemotherapy in patients with recurrent malignant gliomas who failed bevacizumab

    Beverly D. Fu, Mark E. Linskey, Daniela Annenelie Bota
    e6
    24-02-2012
    https://doi.org/10.4081/dts.2012.e6
    1508
    PDF: 728
  • Challenges and limitations of targeting cancer stem cells and/or the tumour microenvironment

    Juan Sebastian Yakisich
    e10
    10-05-2012
    https://doi.org/10.4081/dts.2012.e10
    4892
    PDF: 1270
  • Evaluation of the antimicrobial effects of atracurium, rocuronium and mivacurium. Antimicrobial effects of muscle relaxants

    Volkan Hanci, Fusun Cömert, Hilal Ayoğlu, Canan Kulah, Serhan Yurtlu, Işıl Ozkoçak Turan
    e2
    29-12-2010
    https://doi.org/10.4081/dts.2011.e2
    1250
    PDF: 863
    HTML: 1032
1 - 4 of 4 items

  • Challenges and limitations of targeting cancer stem cells and/or the tumour microenvironment
    6
  • Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine
    6
  • Development of a drug safety ePlatform for physicians, pharmacists, and consumers based on post-marketing adverse events
    5
  • Bevacizumab and etoposide combination chemotherapy in patients with recurrent malignant gliomas who failed bevacizumab
    4
  • Formulation, development and evaluation of injectable formulation of Aspirin
    3

Keywords

Analytics

Analytics

Drugs and Therapy Studies

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

pISSN: 2038-9493
eISSN: 2038-9507

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.